Samsara BioCapital, LLC

Q3 2026 13F-HR Holdings

Location
Palo Alto, CA
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
27
Total value ($000)
$1,051,599
Net value change ($000)
-165,863 (-13.6%)
New positions
4
Sold out positions
1
Turnover %
2.6%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ALAMAR BIOSCIENCES INC 17,312 25.8%
SEPN 14,526 13.8%
PMVP 12,091 NEW
OBSIDIAN THERAPEUTICS INC 11,494 NEW
SGP 7,891 16.8%
PARABILIS MEDICINES INC 2,736 18.0%
TCGX ACQUISITION CORP 1,251 NEW
GOSSAMER BIO INC 1,042 NEW
AQST 871 8.4%
ELOXX PHARMACEUTICALS INC 572 10.3%
Top Reduces (Value $000, Stocks/ETFs)
ALMS -125,081 -70.1%
SRRK -46,076 -12.1%
STRO -18,164 -51.5%
KLRS -15,199 -29.0%
MLYS -10,861 -6.9%
JBIO -6,015 -36.8%
XFOR -2,609 -40.0%
ARTV -2,463 -26.6%
NGNE -2,061 -3.8%
ABVX -1,886 -25.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type